All stock reports

MEDICAMEQ evidence report

Evidence date: 2026-10-01. Research observations only.

What can I do with this stock?

Evaluated 2026-10-02T01:37:53.224812+00:00. Closed-session evidence: 2026-10-01. This is a timestamped assessment, not a live trading feed.

Strategy evidence, instrument feasibility and portfolio suitability are separate. Portfolio suitability has not been assessed.

Today: intraday

Evidence unavailable

No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

  • No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

Next week: five trading sessions

No qualifying opportunity

No candidate with a primary five-session horizon in the coherent source run.

  • No candidate with a primary five-session horizon in the coherent source run.

Long term: one to three years

Research only

A financial screen alone does not establish an investment recommendation.

  • Financial data quality flags require resolution.
  • A current, source-backed thesis and valuation review is required.

Investment evidence

Statement coverage
FULL_STATEMENTS
Financial source retrieved
2026-09-22T14:02:07.508772+00:00

Metrics

latest_annual_period
2026-03-31
revenue
1977697000.0
net_income
96413000.0
operating_cash_flow
-349306000.0
free_cash_flow
-397084000.0
total_assets
3719884000.0
total_liabilities
964384000.0
total_equity
2755500000.0
cash
312642000.0
total_debt
477836000.0
revenue_growth
0.21669090577998262
earnings_growth
0.3563630736332686
net_margin
0.048750137154478165
roe
0.034989294138994737
debt_to_equity
0.1734117220105244
cash_conversion
-3.6230176428489935
free_cash_flow_margin
-0.20078100942662097
trailing_pe
Not supplied
forward_pe
Not supplied
peg_ratio
Not supplied
price_to_book
Not supplied
dividend_yield
Not supplied

Other positional research

No qualifying opportunity

No candidate at another positional horizon in the coherent source run.

  • No candidate at another positional horizon in the coherent source run.
Decision provenance and limitations
Decision ID
decision-351f7d8cb29071450fae9c5363c4299e0cb61f14076198b91c94095446b1ec74
Policy
stock-decisions-v1
Evidence bundle hash
05c62858a2fb0a3b87a6f93f33b09ee774e79c3e5e9d939c40a487c42f2a4dd7
  • market-brief: a7de4d64fedac164d48cdfb9b4081a4666d7f797f7d9c58da304b329b3a61d3c
  • validation-registry: b1069587129bfc64a703cdf8322d0294692585b7d67f5472593e4164bbb0c3bc
  • financial-statements: 0c3cc3183ddbdfe7fa136c667c4c04aa22e057d72019ef3da3ac2661111b912a
  • daily-price: ac6b7d265f532cb9f5943a7e8c02345a9a9a52b4d7730f92a636b97ecf50c5dc
  • Conditional research decisions are not orders or personalized position sizes.
  • Scenario payoffs are assumptions, not probabilities or expected returns.
  • A stop price does not guarantee a maximum loss through a gap or illiquidity.

Download the decision evidence as JSON

Evidence briefing

The local language model selected and grouped the following supplied facts.

Overview

The cached financial metric revenue growth is 0.21669090577998262. The cached financial metric net margin is 0.048750137154478165. The cached financial metric roe is 0.034989294138994737. The trailing 5-session price return was 3.95%. The trailing 20-session price return was 20.46%. The trailing 60-session price return was 27.15%.

Risks

Financial data check: weak_cash_conversion: operating cash flow/net income below 0.5. The cached financial metric cash conversion is -3.6230176428489935. The cached financial metric free cash flow margin is -0.20078100942662097. The closing price was -23.18% below its highest close in the available trailing year. Historical observations do not establish future returns. No verified current news or catalyst evidence is supplied.

Follow Up

Price source verification: REPAIRED. Average cached traded value over twenty sessions was INR 29,925,234. Fundamental coverage is FULL_STATEMENTS; retrieved 2026-09-22T14:02:07.508772+00:00 from EODHD. The cached financial metric latest annual period is 2026-03-31.

Cached observations and evidence limits